Lord, Abbett & Co. LLC Tarsus Pharmaceuticals, Inc. Transaction History
Lord, Abbett & Co. LLC
- $30.6 Billion
- Q2 2024
A detailed history of Lord, Abbett & Co. LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 463,240 shares of TARS stock, worth $21.9 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
463,240
Previous 82,226
463.37%
Holding current value
$21.9 Million
Previous $2.99 Million
321.24%
% of portfolio
0.04%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding TARS
# of Institutions
159Shares Held
40.9MCall Options Held
37.9KPut Options Held
808K-
Rtw Investments, LP New York, NY3.41MShares$161 Million1.55% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$155 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$115 Million2.68% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$107 Million7.48% of portfolio
-
Cowen And Company, LLC2.2MShares$104 Million1.53% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.26B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...